Ionic Pharmaceuticals

Brookline, MA 02445

SBIR Award Summary

Total Number of Awards 4
Total Value of Awards $945K
First Award Date 09/01/12
Most Recent Award Date 03/15/17

Key Personnel

Last Name Name Awards Contact
Wathier Michel Christopher Wathier 3
COLBY AARON HENRY COLBY 1

4 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-16-302
Budget: 03/15/17 - 02/28/18

ABSTRACT A primary challenge in ovarian cancer is preventing tumor recurrence in patients following a resection / debulking procedure (5-year survival rate <45%). Intraperitoneal (IP) administration of chemotherapy (most notably paclitaxel) can improve patient outcomes and prevent local tumor recurrence (the principal deterrent to long-term surv...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-234
Budget: 09/15/14 - 08/31/15

DESCRIPTION (provided by applicant): Despite aggressive multimodality therapy combining surgery, radiation, and/or chemotherapy, mesothelioma is a nearly universally fatal cancer with the majority of patients succumbing to symptoms of local recurrence. To date, there is no effective cure for this disease and there is no way to prevent local recu...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-088
Budget: 05/01/14 - 04/30/15

Abstract Currently, there are no molecular probes that are specifically designed for quantitative imaging of articular cartilage health. In osteoarthritis (OA), the articular cartilage becomes degraded with loss of glycosaminoglycans (GAGs) from the cartilage matrix serving as an early biomarker of the disease process. As such, there are clinica...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-088
Budget: 09/01/12 - 08/31/14

DESCRIPTION (provided by applicant): There is no known cure for Osteoarthritis (OA), a debilitating disease that afflicts 27 million people and costs $125 billion, annually. In OA, the articular cartilage is degraded and it has a limited capacity to self-heal;therefore, rendering a diagnosis at a late stage is ineffective at preventing further c...